Case report: Clinical highlights and radiological classification of IgG4-related spinal pachymeningitis: A rare case series and updated review of the literature

Purpose Hypertrophic pachymeningitis associated with immunoglobulin G4-related disease (IgG4-RD) has been rarely reported, and there is little information and no clear consensus on the management of IgG4-related spinal pachymeningitis (IgG4-RSP). The present study described its possible clinical features, including the symptoms, imaging, treatment and prognosis of patients with IgG4-RSP. Methods We report three patients who presented with progressive neurological dysfunction due to spinal cord compression. Relevant articles were searched from the PubMed, Web of Science, and Embase databases, and the resulting literature was reviewed. Results The literature review provided a summary of 45 available cases, which included three cases from our center. Progressive worsening of neurological impairment was observed in 22 patients (48.9%). The lesions involved the thoracic spine (n=28, 62.2%), cervical spine (n=26, 57.8%), lumbar spine (n=9, 20.0%), and sacral spine (n=1, 2.2%). Furthermore, the lesions were located in the dura mater (n=18, 40.0%), epidural space (n=17, 37.8%), intradural-extramedullary space (n=9, 20.0%), and intramedullary space (n=1, 2.2%). On magnetic resonance imaging (MRI), the lesions generally appeared as striated, fusiform, or less often lobulated oval changes, with homogeneous (n=17,44.7%) and dorsal (n=15,39.5%) patterns being the most common. Thirty-five patients had homogeneous T1 gadolinium enhancement. Early surgical decompression, corticosteroid treatment, and steroid-sparing agents offered significant therapeutic advantages. A good therapeutic response to disease recurrence was observed with the medication. Conclusion The number of reported cases of IgG4-RSP remains limited, and patients often have progressive worsening of their neurological symptoms. The features of masses identified on the MRI should be considered. The prognosis was better with decompression surgery combined with immunosuppressive therapy. Long-term corticosteroid treatment and steroid-sparing agent maintenance therapy should be ensured. A systemic examination is recommended to identify the presence of other pathologies.

[1]  S. Gil-Perotín,et al.  NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity , 2022, Journal of Neurology.

[2]  H. Urbach,et al.  Freiburg Neuropathology Case Conference , 2021, Clinical Neuroradiology.

[3]  Rajeev Sharma,et al.  IgG4-Related Disease in Intradural Extramedullary Location- Detailed Case Illustration and Literature Review with Special Emphasis on Role of Surgery in its Management , 2021, Neurology India.

[4]  P. Woo,et al.  The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases , 2021, Chinese Neurosurgical Journal.

[5]  A. Ozpinar,et al.  Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case , 2020, Clinical Neurology and Neurosurgery.

[6]  R. Darwazeh,et al.  Immunoglobulin G4-related Hypertrophic Pachymeningitis of the Spine: A Case Report and Systematic Review of the Literature. , 2020, World neurosurgery.

[7]  L. Zuo,et al.  Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report , 2020, Journal of Neuroimmunology.

[8]  Saijilafu,et al.  Decoding epigenetic codes: new frontiers in exploring recovery from spinal cord injury , 2020, Neural regeneration research.

[9]  M. Anagnostouli,et al.  Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review , 2020, Rheumatology International.

[10]  R. Sánchez-Oro,et al.  Review of IgG4-related disease. , 2019 .

[11]  Amish J. Dave,et al.  Spinal IgG4-related hypertrophic pachymeningitis with spinal cord compression case report. , 2019, World neurosurgery.

[12]  S. Wright,et al.  IgG4-Related Sclerosing Disease Causing Spinal Cord Compression: The First Reported Case in Literature , 2019, Case reports in immunology.

[13]  N. Girard,et al.  Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review. , 2019, Seminars in arthritis and rheumatism.

[14]  D. Fontaine,et al.  Immunoglobulin G4-related hypertrophic pachymeningitis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[15]  M. Kawakami,et al.  Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature , 2019, Immunologic Research.

[16]  D. Waitzman,et al.  Neurologic IgG4-Related Disease , 2018, The Neurohospitalist.

[17]  M. Uppin,et al.  A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease , 2019, Annals of Indian Academy of Neurology.

[18]  N. Vila-Chã,et al.  Clinical features of hypertrophic pachymeningitis in a center survey , 2019, Neurological Sciences.

[19]  C. Horbinski,et al.  Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression , 2018, Surgical neurology international.

[20]  C. Marini,et al.  Neurological involvement of IgG4-related disease: description of a case and review of the literature , 2018, The neuroradiology journal.

[21]  Y. Zen,et al.  Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease , 2015, Oncotarget.

[22]  Khoi D. Than,et al.  IgG4-related disease presenting as intradural extramedullary lesion: a case report and review of the literature , 2019, British journal of neurosurgery.

[23]  C. Zuo,et al.  FDG PET/CT in Immunoglobulin G4-Related Spinal Hypertrophic Pachymeningitis. , 2017, Clinical nuclear medicine.

[24]  M. Kawano,et al.  New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases , 2017, Arthritis Research & Therapy.

[25]  P. Faust,et al.  IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity. , 2017, Clinical imaging.

[26]  A. Fernández-Codina,et al.  Alteration of IgG4 levels in cerebrospinal fluid in IgG4‐related disease , 2017, International journal of rheumatic diseases.

[27]  C. Campochiaro,et al.  Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[28]  D. D'cruz,et al.  Neurologic Manifestations of Systemic Disease (n Scolding and C Rice, Section Editors) Neurological Manifestations of Igg4-related Disease , 2022 .

[29]  P. Arnold,et al.  Immunoglobulin G4-related epidural inflammatory pseudotumor presenting with pulmonary complications and spinal cord compression: case report. , 2017, Journal of neurosurgery. Spine.

[30]  M. de Vincentiis,et al.  Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease , 2017, Immunologic research.

[31]  E. Mendel,et al.  Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. , 2017, Journal of neurosurgery. Spine.

[32]  P. Floridi,et al.  IgG4-related cranio-spinal hypertrophic pachymeningitis involving the internal auditory canal. , 2017, Journal of biological regulators and homeostatic agents.

[33]  H. Sekiguchi,et al.  IgG4‐Related Disease: Retrospective Analysis of One Hundred Sixty‐Six Patients , 2016, Arthritis & rheumatology.

[34]  B. Radotra,et al.  An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases. , 2016, Journal of neurosurgery. Spine.

[35]  Jinming Li,et al.  Diagnostic Value of Serum IgG4 for IgG4-Related Disease , 2016, Medicine.

[36]  N. Ferreira,et al.  IgG4-related disease presenting with an epidural inflammatory pseudotumor: a case report , 2016, Journal of Medical Case Reports.

[37]  C. Doglioni,et al.  IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients , 2016, Scandinavian Journal of Rheumatology.

[38]  N. Scolding,et al.  Intracranial spread of IgG4-related disease via skull base foramina , 2016, Practical Neurology.

[39]  L. Xia,et al.  IgG4-related spinal pachymeningitis , 2016, Clinical Rheumatology.

[40]  C. Doglioni,et al.  Immunology of IgG4‐related disease , 2015, Clinical and experimental immunology.

[41]  G. Leung,et al.  IgG4-Related Hypertrophic Pachymeningitis at the Falx Cerebrii with Brain Parenchymal Invasion: A Case Report. , 2015, World neurosurgery.

[42]  J. Stone,et al.  International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease , 2015, Arthritis & rheumatology.

[43]  J. Stone,et al.  IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients , 2015, Arthritis & rheumatology.

[44]  V. Schnadig,et al.  Hypertrophic spinal pachymeningitis: Idiopathic vs. IgG4-related , 2014, Journal of the Neurological Sciences.

[45]  Joo Sup Kim,et al.  Paraplegia in a Patient With IgG4-Related Sclerosing Disease: A Case Report , 2014, Annals of rehabilitation medicine.

[46]  J. Stone,et al.  IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. , 2014, JAMA neurology.

[47]  J. Michaud,et al.  IgG4-related Disease Presenting as Dural Thickening — A Rare Cause of Myelopathy , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[48]  Arezou Khosroshahi,et al.  Brief Report: Spuriously Low Serum IgG4 Concentrations Caused by the Prozone Phenomenon in Patients With IgG4‐Related Disease , 2014, Arthritis & rheumatology.

[49]  K. Okazaki,et al.  Comprehensive Diagnostic Criteria for IgG4-Related Disease , 2014 .

[50]  D. Gnepp,et al.  A mysterious back pain. , 2014, Journal of postgraduate medicine.

[51]  H. Tomimoto,et al.  [IgG4-related disease that presented cranial, cervical, lumbar and sacral hypertrophic pachymeningitis associated with infundibulo-hypophysitis]. , 2014, Rinsho shinkeigaku = Clinical neurology.

[52]  C. Doglioni,et al.  Cerebrospinal Fluid Analysis in Immunoglobulin G4-related Hypertrophic Pachymeningitis , 2013, The Journal of Rheumatology.

[53]  J. Stone,et al.  IgG4-Related Disease and Hypertrophic Pachymeningitis , 2013, Medicine.

[54]  M. Kudo,et al.  Toll-like receptor activation in basophils contributes to the development of IgG4-related disease , 2013, Journal of Gastroenterology.

[55]  D. Sahani,et al.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. , 2012, Arthritis and rheumatism.

[56]  Michael J Levy,et al.  Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience , 2012, Gut.

[57]  Y. Tajima,et al.  Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions , 2012, BMJ Case Reports.

[58]  J. Stone,et al.  Development of an IgG4-RD Responder Index , 2012, International journal of rheumatology.

[59]  O. Matsui,et al.  IgG4-Related Perineural Disease , 2012, International journal of rheumatology.

[60]  C. Doglioni,et al.  IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. , 2012, Annals of internal medicine.

[61]  M. Kudo,et al.  Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. , 2012, Arthritis and rheumatism.

[62]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[63]  Hisanori UmeharaKazuichi A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2012 .

[64]  S. Choi,et al.  IgG4-Related Sclerosing Pachymeningitis Causing Spinal Cord Compression , 2010, Neurology.

[65]  M. Lopes,et al.  IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria , 2010, Acta Neuropathologica.

[66]  J. Chan,et al.  IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. , 2009, American Journal of Surgical Pathology.

[67]  K. Tsubota,et al.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders , 2008, Annals of the rheumatic diseases.

[68]  H. Nakajima,et al.  Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis , 2003, Gut.

[69]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.